Minerva Neurosciences (NERV) Current Leases (2019 - 2021)
Minerva Neurosciences (NERV) posted Current Leases of $16288.0 for Q2 2021, down 74.69% on a QoQ basis from $64350.0 in Q1 2021, and down 91.19% year-over-year from $184777.0 in Q2 2020.
Minerva Neurosciences (NERV) Current Leases (2019 - 2021) Analysis & Trends
Minerva Neurosciences' Current Leases history runs 3 years deep, the most recent figure standing at $16288.0 for Q2 2021.
- Quarterly Current Leases fell 91.19% year-over-year to $16288.0 in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $16288.0 (down 91.19% YoY) and the FY2020 annual result came in at $111229.0, down 35.67% from the prior year.
- Current Leases was $16288.0 for Q2 2021 at Minerva Neurosciences, down from $64350.0 in the prior quarter.
- Across five years, Current Leases topped out at $184777.0 in Q2 2020 and bottomed at $16288.0 in Q2 2021.
- A 3-year average of $137020.8 and a median of $159279.0 in 2019 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2020 — Current Leases grew 14.48% — and 2021, when it plunged 91.19%.
- Minerva Neurosciences' Current Leases stood at $172901.0 in 2019, then plunged by 35.67% to $111229.0 in 2020, then slumped by 85.36% to $16288.0 in 2021.
- Business Quant data shows NERV's Current Leases at $16288.0 in Q2 2021, $64350.0 in Q1 2021, and $111229.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Minerva Neurosciences | 195.10 Mn | 195.10 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 16,288.00 |
| Mar 31, 2021 | 64,350.00 |
| Dec 31, 2020 | 111,229.00 |
| Sep 30, 2020 | 156,956.00 |
| Jun 30, 2020 | 184,777.00 |
| Mar 31, 2020 | 178,765.00 |
| Dec 31, 2019 | 172,901.00 |
| Sep 30, 2019 | 167,181.00 |
| Jun 30, 2019 | 161,602.00 |
| Mar 31, 2019 | 156,159.00 |